Prescription opioids, opioid use disorder, and overdose crisis in Canada: Current dilemmas and remaining questions
Files in This Item:
|Opioid commentary revised_Jan29.pdf||121.21 kB||Adobe PDF||Download Request a copy|
|Title:||Prescription opioids, opioid use disorder, and overdose crisis in Canada: Current dilemmas and remaining questions||Authors:||Gorfinkel, Lauren
|Permanent link:||http://hdl.handle.net/10197/10078||Date:||1-Jun-2018||Online since:||2019-04-23T11:35:04Z||Abstract:||In Canada, a rise in opioid use disorder (OUD) and overdose has been linked to opioid prescriptions in a number of contexts. At the same time, relatively few patients prescribed opioids reportedly develop OUD. This combination of findings suggests a pressing need for research on specific avenues through which medically prescribed opioids influence OUD and overdose in Canada. In this commentary, we therefore discuss a few of the potential processes that might allow for medically prescribed opioids to indirectly influence rising overdose rates, and the processes that might account for inconsistencies between large correlational research and studies of OUD incidence in opioid prescribed patients.||Type of material:||Journal Article||Publisher:||Wolters Klumer||Journal:||Canadian Journal of Addiction||Volume:||9||Issue:||2||Start page:||10||End page:||12||Copyright (published version):||2018 Lippincott Williams||Keywords:||Canada; Prescription opioids; Overdose||DOI:||10.1097/CXA.0000000000000016||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Medicine Research Collection|
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.